Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Simulations Plus Releases MembranePlus 3.0: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Releases MembranePlus 3.0


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced it has

AEVIS VICTORIA SA (AEVS:SW) erzielt 2021 einen Umsatz CHF 895.9 Millionen, 22.2% über Vorjahrhttp://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png
AEVIS VICTORIA SA (AEVS:SW) erzielt 2021 einen Umsatz CHF 895.9 Millionen, 22.2% über Vorjahr
AEVIS VICTORIA SA (AEVS:SW) erzielt 2021 einen Umsatz CHF 895.9 Millionen, 22.2% über Vorjahr
AEVIS VICTORIA SA (AEVS:SW) announces 2021 revenues of CHF 895.9 million, up by 22.2%http://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png
AEVIS VICTORIA SA (AEVS:SW) announces 2021 revenues of CHF 895.9 million, up by 22.2%
AEVIS VICTORIA SA (AEVS:SW) announces 2021 revenues of CHF 895.9 million, up by 22.2%
Simulations Plus to Present at Oppenheimer Annual Healthcare Conference: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus to Present at Oppenheimer Annual Healthcare Conference


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting

Simulations Plus to Present at Raymond James Institutional Investors Conference: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus to Present at Raymond James Institutional Investors Conference


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting

NanoString Technologies Releases Fourth Quarter and Full Year 2021 Operating Results and Provides 2022 Financial Outlook: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString Technologies Releases Fourth Quarter and Full Year 2021 Operating Results and Provides 2022 Financial Outlook


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the fourth quarter and year

AEVIS VICTORIA SA (AEVS:SW): Division Hospitality erwirbt Hotel L'Oscar im Zentrum von London für GBP 60 Millionen.http://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png
AEVIS VICTORIA SA (AEVS:SW): Division Hospitality erwirbt Hotel L'Oscar im Zentrum von London für GBP 60 Millionen.
AEVIS VICTORIA SA (AEVS:SW): Division Hospitality erwirbt Hotel L'Oscar im Zentrum von London für GBP 60 Millionen.
AEVIS VICTORIA SA (AEVS:SW): Hotel division acquires hotel L'Oscar in central London for GBP 60 million.http://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png
AEVIS VICTORIA SA (AEVS:SW): Hotel division acquires hotel L'Oscar in central London for GBP 60 million.
AEVIS VICTORIA SA (AEVS:SW): Hotel division acquires hotel L'Oscar in central London for GBP 60 million.
NanoString to Webcast Presentation from the 42nd Annual Cowen Health Care Conference: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString to Webcast Presentation from the 42nd Annual Cowen Health Care Conference


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a

STAAR Surgical Reports Fourth Quarter and Full Year 2021 Results: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical Reports Fourth Quarter and Full Year 2021 Results


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the

AtriCure Reports Fourth Quarter 2021 and Full Year 2021 Financial Results
AtriCure Reports Fourth Quarter 2021 and Full Year 2021 Financial Results


AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management

DGAP-HV: MeVis Medical Solutions AG: Bekanntmachung der Einberufung zur Hauptversammlung am 23.03.2022 in Bremen mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
DGAP-HV: MeVis Medical Solutions AG: Bekanntmachung der Einberufung zur Hauptversammlung am 23.03.2022 in Bremen mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
DGAP-HV: MeVis Medical Solutions AG: Bekanntmachung der Einberufung zur Hauptversammlung am 23.03.2022 in Bremen mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 23, 2022: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 23, 2022


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release

NanoString to Webcast Presentation from the 11th Annual SVB Leerink Global Healthcare Conference: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString to Webcast Presentation from the 11th Annual SVB Leerink Global Healthcare Conference


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a

Simulations Plus to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be

NanoString to Release Fourth Quarter and Fiscal Year 2021 Operating Results and Host Conference Call on Tuesday, March 1, 2022: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString to Release Fourth Quarter and Fiscal Year 2021 Operating Results and Host Conference Call on Tuesday, March 1, 2022


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will release fourth quarter and

Simulations Plus Partners with Large Pharmaceutical Company to Drive Advancements to the GastroPlus Mechanistic Oral Absorption Model: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Partners with Large Pharmaceutical Company to Drive Advancements to the GastroPlus Mechanistic Oral Absorption Model


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced a new

Simulations Plus Enters New Collaboration with Leading Animal Health Company: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Enters New Collaboration with Leading Animal Health Company


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced a new

Simulations Plus to Present at Sidoti Winter Small Cap Investor Conference: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus to Present at Sidoti Winter Small Cap Investor Conference


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that chief executive officer Shawn

NanoString Reports Inducement Grant Under Nasdaq Listing Rules: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString Reports Inducement Grant Under Nasdaq Listing Rules


NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today reported, as required by Nasdaq Stock Market Rules, an equity

STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2021 Results: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2021 Results


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided preliminary results for the

Owens & Minor, Inc. Signs Definitive Agreement to Acquire Apria, Inc.: https://mms.businesswire.com/media/20211103005246/en/922805/5/O%26M_LogoTM_hi-res.jpg
Owens & Minor, Inc. Signs Definitive Agreement to Acquire Apria, Inc.


Owens & Minor, Inc. (“Owens & Minor”) (NYSE: OMI) and Apria, Inc. (“Apria”) (Nasdaq: APR) today announced that the companies have entered into a definitive agreement pursuant to which Owens & Minor

NanoString Announces Commercial Leadership Transition: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString Announces Commercial Leadership Transition


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced a commercial leadership transition. Chad Brown, who

NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2021: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2021


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for

Simulations Plus Reports First Quarter Fiscal 2022 Financial Results: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Reports First Quarter Fiscal 2022 Financial Results


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its first